Hjem › Type 2-diabetes › Tennessee
Kliniske studier for Type 2-diabetes i Tennessee
18 studier for Type 2-diabetes søker deltakere på steder i Tennessee.
Byer i Tennessee
Offisiell studietekst (engelsk)
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Clinical Research Associates, Nashville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Alliance for Multispecialty Research, LLC-Knoxville-69693, Knoxville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- University Diabetes & Endocrine Consultants, Chattanooga
- LifeDoc Research, PLLC, Memphis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Community DPC, Cleveland
- University of Tennessee Medical Center, Knoxville
- TriStar Centennial Medical Center (HCA Health Care), Nashville
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 55 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06112418A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Franklin
- Research Site, Jackson
- Research Site, Knoxville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Memphis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743450A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- CNS Healthcare, Memphis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Southeast Renal Research Institute, Chattanooga
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- LifeDoc Health, Memphis
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Memphis
- Research Site, Morristown
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- LifeDoc Health, Memphis
RekruttererFase 3
Alder 10 til 18 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07282613AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Holston Medical Group Pc, Bristol
- The Alliance for Multispecialty Research LLC AMR, Knoxville
- MidState Endocrine Associates, Nashville
RekruttererFase 3
Alder 45 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Kingsport
- Research Site, Nashville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Knoxville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07662044A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Memphis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07664553Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- University of Diabetes and Endocrine Consultants, Chattanooga
Rekrutterer
Alder 18 til 75 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07521475Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT06852950Gut Microbiota in Metabolic Surgery
- Vanderbilt_University MC, Nashville
RekruttererObservasjonsstudie
Alder 21 til 65 · Alle kjønn · Oppdatert 4. nov. 2025 · NCT05000996Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.